Glucose Patterns in Women With Polycystic Ovary Syndrome
Measures blood sugar over time using a sensor in adult women with polycystic ovary syndrome.
Plain-language title generated from the registry record
Registry title: Glucose Profiles in Women With Polycystic Ovary Syndrome
Key facts
- Where
- Salouël, FranceSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult women with polycystic ovary syndrome (PCOS). Their glucose levels will be tracked with a sensor to compare patterns across PCOS types.
- Age
- Over 18 years
- Sex
- Women only
- Disease stage
- Polycystic ovary syndrome, shown by at least 2 of 3 signs: irregular periods, high male hormones (by exam or blood test), polycystic ovaries on ultrasound or high AMH levels. Other causes must be ruled out.
- Earlier treatment
- Must not have taken estrogen-progestin or progestin contraception, diabetes drugs, inositol or anti-androgen drugs in the 3 months before joining.
Main reasons for not taking part
- Pregnancy or breast-feeding
- Other conditions with similar signs, such as hyperprolactinemia, thyroid problems, Cushing's syndrome, congenital adrenal hyperplasia, a virilizing tumor or taking exogenous androgens
- Diabetes already diagnosed before the trial
- Treatment with contraception, diabetes drugs, inositol or anti-androgens in the last 3 months
Read by machine on 13 November 2026.
Where in France
- CHRU AmiensSalouël, FranceContact: Al-Sallameh Abdallah, PrTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Centre Hospitalier Universitaire, Amiens
- Trial code
- NCT07483723
- Record updated
- 19 March 2026
- Original description
Polycystic ovary syndrome is a very common condition that is associated with metabolic complications. Patients with polycystic ovary syndrome exhibit insulin resistance and are at greater risk to develop type 2 diabetes. This syndrome is heterogeneous, classified according to 4 phenotypes (A-D). It seems that certain phenotypes are less exposed to insulin resistance and metabolic complications. However, only a few studies have evaluated the glucose profile according to phenotype. New technologies now make it possible to monitor glucose levels continuously. The aim of this project is to evaluate glucose profile parameters using continuous glucose monitoring, and to compare these profiles according to different PCOS phenotypes.Read full original descriptionShow less
Glucose Profiles in Women With Polycystic Ovary Syndrome
Polycystic ovary syndrome is a very common condition that is associated with metabolic complications. Patients with polycystic ovary syndrome exhibit insulin resistance and are at greater risk to develop type 2 diabetes. This syndrome is heterogeneous, classified according to 4 phenotypes (A-D). It seems that certain phenotypes are less exposed to insulin resistance and metabolic complications. However, only a few studies have evaluated the glucose profile according to phenotype. New technologies now make it possible to monitor glucose levels continuously. The aim of this project is to evaluate glucose profile parameters using continuous glucose monitoring, and to compare these profiles according to different PCOS phenotypes.
Inclusion: Age > 18 years at inclusion criteria; Patient with polycystic ovary syndrome, defined by the presence of at least 2/3 irregular menstrual cycles, clinical or biological hyperandrogenism, polycystic ovary morphology (pelvic ultrasound) or elevated AMH levels, after the exclusion of other disorders; Agreed to carry the FSL pro; Signed informed consent.
Exclusion: Patient treated within 3 months prior to inclusion/data collection with estrogen-progestin contraception, progestin contraception, antidiabetic drugs, inositol, antiandrogen; Differential diagnoses: hyperprolactinemia, dysthyroidism, Cushing's syndrome, congenital adrenal hyperplasia, virilizing tumor (ovarian or adrenal), intake of exogenous androgens; Pre-existing diabetes; Pregnancy, breast-feeding.